This page shows the latest BI news and features for those working in and with pharma, biotech and healthcare.
The trial also met its secondary endpoint, demonstrating that BI 1015550 showed acceptable safety and tolerability in IPF patients after 12 weeks. ... Boehringer Ingelheim will begin a phase 3 clinical trial programme to continue investigating if BI
AMX-818 expected to enter the clinic in early 2022. Amunix’s technology offers the potential to overcome challenges that have plagued the adoption of T-Cell Engager bi-specific antibodies
One possible attraction for the White House is that Califf was easily confirmed in 2016 with strong bi-partisan support in the Senate.
Boehringer seems to have been reviewing its partnerships recently. In August, CureVac announced BI had pulled the plug on their long-running partnersip to develop an mRNA cancer vaccine, while in ... disease outbreaks, giving time for the BI’s drug
After starting ART, the patients also received bi-weekly doses of either vesatolimod or placebo as an add-on therapy, and then came off therapy while they were monitored for a
Boehringer Ingelheim took a different tack with its Alzheimer’s candidate BI 409306, which targeted PDE9, but that drug also failed mid-stage testing and was unable to show any improvement
More from news
Approximately 4 fully matching, plus 98 partially matching documents found.
Since the initiative launched, AstraZeneca has seen two consecutive increases in the bi-annual employee engagement survey, with 69% of AstraZeneca employees agreeing that ‘Together, we are making progress in our
attractive and valuable bi-product.
Boehringer Ingelheim granted Amgen worldwide rights to BI 836909, a bispecific T cell engager designed to treat multiple myeloma. ... Under the agreement, Daiichi Sankyo will acquire a licence to Zymeworks' platforms to develop a bi-specific antibody
But you can deal with the other three factors. This is where Boehringer has a key strength because there is a very, very strong culture, which is built on our BI
1, 200. ZymeWorks (US). GSK (UK). License and option. Preclinical bi-specific antibodies based on Azymetric platform for treatment of solid tumours.
More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.
We talk a lot about using emotions in healthcare communications, but not as much about the business intelligence(BI) behind it. ... What we don’t talk about as much is the business intelligence (BI) behind it.
patient voice and the critical role of BI in ensuring this is heard.
AbbVie. ALK. Astellas. AstraZeneca. Bayer. Boehringer Ingelheim. BI. BMS. Celgene. Sanofi Genzyme.
CSL are a healthcare specialist business intelligence consultancy. We help companies utilise tools like Power BI &Tableau.
other data to augment intelligence and reveal actionable insights using Tableau and Power BI.
More from PMHub
Approximately 1 fully matching, plus 13 partially matching documents found.
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...